Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 73.22
-0.71 (-0.96%)
Jul 28, 2026, 3:32 PM AEST
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Apogee Therapeutics stock at 1.59%, Erasca at 1.42%, Oruka Therapeutics at 1.41%, Kymera Therapeutics at 1.39%, and Dianthus Therapeutics at 1.35%.
Total Holdings
10
Top 10 Percentage
13.68%
Asset Class
Equity
ETF Category
Health Care
Assets
47.75M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | APGE | Apogee Therapeutics, Inc. | 1.59% |
| 2 | ERAS | Erasca, Inc. | 1.42% |
| 3 | ORKA | Oruka Therapeutics, Inc. | 1.41% |
| 4 | KYMR | Kymera Therapeutics, Inc. | 1.39% |
| 5 | DNTH | Dianthus Therapeutics, Inc. | 1.35% |
| 6 | TWST | Twist Bioscience Corporation | 1.34% |
| 7 | PRAX | Praxis Precision Medicines, Inc. | 1.32% |
| 8 | SYRE | Spyre Therapeutics, Inc. | 1.31% |
| 9 | RVMD | Revolution Medicines, Inc. | 1.29% |
| 10 | CGON | CG Oncology, Inc. | 1.27% |
As of Jul 23, 2026